Skip to content
PubMed This is a summary of 5 peer-reviewed journal articles Updated
Pediatric Rheumatology · LACC1-Associated Juvenile Arthritis

Recognizing Symptoms and Emergency Red Flags

At a Glance

LACC1-associated juvenile arthritis often begins before age 2 and may cause recurrent fever, salmon-colored rash, painful swollen joints, erosive damage, and persistent limb swelling. Breathing trouble, confusion, unusual bleeding, jaundice, or a distended belly require immediate emergency care.

While LACC1-associated juvenile arthritis can look different from one child to the next, it typically presents with one of two reported phenotypes. It may appear as systemic JIA (affecting the whole body with fevers and rashes) or as polyarticular JIA (affecting many joints simultaneously) [1][2]. Because this is an autoinflammatory disease, the symptoms are often more aggressive and occur much earlier than in typical arthritis—often before a child’s second birthday [3][1].

Common Clinical Signs

Parents often notice that their child’s symptoms are persistent and do not respond well to standard over-the-counter anti-inflammatory medications.

  • Early-Onset Fever and Rash: High fevers that come and go, often accompanied by a faint, salmon-colored rash, are common in the systemic version of the disease [1].
  • Erosive Joint Damage: One of the most significant features of this condition is its impact on the joints. In a reported cohort of 43 patients, approximately 86% of children developed progressive erosive arthritis [1]. This means the inflammation is strong enough to physically wear down the bone and cartilage within the joints [3].
  • Limb Swelling: About 23% of children in that same cohort experienced lymphedema, which is persistent swelling in the arms or legs [1]. This happens because the lymphatic system—which manages fluid in the body—is affected by the underlying inflammation. Unlike typical swelling, this may not go away with rest or elevation.

Identifying a Flare-Up

A “flare” is a period when symptoms become more intense. During a typical flare, you may see:

  • Increased joint pain and morning stiffness.
  • New or worsening swelling in multiple joints (polyarthritis) [1].
  • Irritability, fatigue, or a decrease in your child’s activity level.

Red Flags: Macrophage Activation Syndrome (MAS) and Infection

While not yet common in reported LACC1 cases, any child with a systemic-type arthritis is at risk for Macrophage Activation Syndrome (MAS), a risk inferred largely from systemic JIA [1]. This is a life-threatening emergency where the immune system becomes dangerously overactive. It can be difficult to distinguish from a regular flare or severe infection at first, but it is much more severe.

Seek emergency medical care immediately—do not wait for laboratory results or a scheduled appointment—if your child experiences these Red Flags:

  1. Breathing or Cardiovascular Issues: Trouble breathing, rapid breathing, fainting, collapse, or marked pallor (paleness) and weakness.
  2. Neurological Changes: Extreme irritability, unusual sleepiness, confusion, seizures, or an inability to wake the child.
  3. Unusual Bleeding: Easy bruising, nosebleeds, or small red/purple spots on the skin (petechiae) that do not blanch (turn white) when pressed.
  4. Organ Swelling: Jaundice (yellow skin or eyes) or a very firm or distended belly, which may indicate an enlarged liver or spleen (hepatosplenomegaly) [4].

During these emergencies, clinicians assess trends in your child’s laboratory tests—such as a sudden drop in white blood cell counts, platelets, or a rapid spike in ferritin, AST, triglycerides, and fibrinogen [4][5]. Families should not wait for these tests before seeking help.

Create a Safety Action Plan

Work with your rheumatologist to create a one-page written emergency plan. This should include:

  • The direct rheumatology contact number and emergency department instructions.
  • Your child’s exact medication list (including doses that must never be stopped suddenly, like steroids).
  • Your child’s baseline laboratory values.
  • Specific instructions on who to call for fever or suspected infection while on immunosuppressive medications.

Common questions in this guide

What symptoms can LACC1-associated juvenile arthritis cause?
It can cause recurring high fevers, a faint salmon-colored rash, painful or stiff joints, swelling in several joints, fatigue, irritability, and reduced activity. Some children develop progressive erosive joint damage or persistent swelling of the arms or legs from lymphedema. The pattern may resemble systemic or polyarticular juvenile idiopathic arthritis.
How can I tell whether my child is having a flare?
A flare often causes more joint pain and morning stiffness, new or worsening swelling in several joints, and lower energy or activity. Fever and rash may also become more noticeable in systemic-type disease. A rheumatologist should help distinguish a flare from infection or a serious complication.
What are the emergency warning signs of macrophage activation syndrome?
Macrophage activation syndrome is a life-threatening overactivation of the immune system that can initially look like a flare or severe infection. Seek emergency care immediately for trouble breathing, rapid breathing, fainting, collapse, marked paleness or weakness, confusion, extreme sleepiness, seizures, or inability to wake the child. Easy bruising, nosebleeds, nonblanching red or purple spots, yellow skin or eyes, or a firm or distended belly are also red flags, and you should not wait for lab results.
Does persistent swelling in a child’s arms or legs need evaluation?
Yes. Persistent limb swelling may be lymphedema, but it can have other causes and should be assessed by the child’s rheumatology team. Swelling that does not improve with rest or elevation should be documented and discussed promptly.
What should an emergency plan for LACC1-associated juvenile arthritis include?
A written plan should list the rheumatology contact and emergency department instructions, every medication and dose, and medicines such as steroids that must not be stopped suddenly. It should also include baseline laboratory values and clear instructions for fever or suspected infection while the child takes immunosuppressive medicines. Keep the plan easy to find and update it with the care team.
Which laboratory changes do doctors watch for when macrophage activation syndrome is suspected?
Clinicians may track a sudden drop in white blood cells and platelets and changes in ferritin, AST, a liver enzyme, triglycerides, and fibrinogen. These trends help assess a possible emergency, but families should seek care based on warning signs and should not delay to obtain laboratory results.

Get notified when new evidence is published on juvenile arthritis due to defect in LACC1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (5)
  1. 1

    New or vanishing frontiers: LACC1-associated juvenile arthritis.

    Al-Mayouf SM, Yateem M, Al-Dusery H, et al.

    International journal of pediatrics & adolescent medicine 2021; (8(1)):44-47 doi:10.1016/j.ijpam.2020.11.005.

    PMID: 33718577
  2. 2

    Clinical characteristics and genotype analysis of a Chinese patient with juvenile arthritis due to novel LACC1 frameshift mutation and literature review.

    Wu Y, Wang S, Yin W, et al.

    Molecular genetics & genomic medicine 2023; (11(7)):e2175 doi:10.1002/mgg3.2175.

    PMID: 37186377
  3. 3

    [Monogenic variants in Laccase domain-containing 1 (LACC1) as the cause of juvenile arthritis].

    Knieper AM, von Stuckrad ASL, Minden K, et al.

    Zeitschrift fur Rheumatologie 2024; (83(1)):4-14 doi:10.1007/s00393-023-01442-2.

    PMID: 37921883
  4. 4

    Macrophage Activation Syndrome secondary to Systemic Juvenile Idiopathic Arthritis: A Case Report.

    Kafle R, Bhatta A, Gami S, et al.

    JNMA; journal of the Nepal Medical Association 2021; (59(243)):1166-1169 doi:10.31729/jnma.7019.

    PMID: 35199753
  5. 5

    Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience.

    Høeg PE, Glerup M, Mahler B, et al.

    International journal of rheumatology 2022; (2022()):1784529 doi:10.1155/2022/1784529.

    PMID: 35936656

This page is for informational purposes only and does not constitute medical advice. It cannot replace your child’s rheumatologist or emergency medical care, especially when red-flag symptoms occur.